Dietrich A. Stephan's most recent trade in NeuBase Therapeutics Inc was a trade of 655,000 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 655,000 | 1,471,775 (8%) | 3% | 0 | Common Stock | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 655,000 | 1,864,680 | - | - | Stock option (right to buy) | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 306,000 | 306,000 | - | - | Employee Stock option (right to buy) | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 26 Apr 2021 | 12,000 | 24,525 (0%) | 0% | 5 | 60,000 | Common Stock |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2020 | 2,547,639 | 2,547,639 (14%) | 14% | 0 | Common Stock | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2020 | 1,273,820 | 1,273,819 (7%) | 7% | 0 | Common Stock | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2020 | 1,273,819 | 2,547,639 (14%) | 7% | 0 | Common Stock | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2020 | 1,273,819 | 2,547,639 (14%) | 7% | 0 | Common Stock | |
NeuBase Therapeutics Inc | Dietrich A. Stephan | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 164,925 | 164,925 | - | - | Stock option (right to buy) |